McKesson agrees to $350 million settlement

Without admitting guilt, pharmaceutical distributor McKesson has agreed to settle a suit brought against it by the New England Carpenters Health Benefits Fund, to the tune of $350 million.

The suit claimed that McKesson conspired with First DataBank in 2001 to artificially raise the spread between wholesale average prices and wholesale average costs of medications, giving pharmacies a bigger profit margin and encouraging them to work with McKesson. First DataBank already settled a similar suit against it in 2006, though it only had to pay $1 million, along with agreeing to fix the mark-up on many drugs on its list.

Meanwhile, McKesson has already set aside a reported $143 million for state and federal suits brought against it on the same charges. It of course continues to deny all charges.

To learn more about the settlement:
- read this Modern Healthcare piece

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.